203 related articles for article (PubMed ID: 33186220)
21. [PALLIATIVE / SUPPORTIVE CARE FOR CHRONIC KIDNEY DISEASE (CKD) PATIENTS].
Fleishman T; Shvartzman P
Harefuah; 2022 May; 161(5):327-332. PubMed ID: 35606920
[TBL] [Abstract][Full Text] [Related]
22. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
Faria M; de Pinho MN
Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
[TBL] [Abstract][Full Text] [Related]
23. Palliative and end-of-life care issues in chronic kidney disease.
Combs SA; Davison SN
Curr Opin Support Palliat Care; 2015 Mar; 9(1):14-9. PubMed ID: 25581447
[TBL] [Abstract][Full Text] [Related]
24. The experiences of close persons caring for people with chronic kidney disease stage 5 on conservative kidney management: contested discourses of ageing.
Low J; Myers J; Smith G; Higgs P; Burns A; Hopkins K; Jones L
Health (London); 2014 Nov; 18(6):613-30. PubMed ID: 24695386
[TBL] [Abstract][Full Text] [Related]
25. Future Avenues to Decrease Uremic Toxin Concentration.
Vanholder RC; Eloot S; Glorieux GL
Am J Kidney Dis; 2016 Apr; 67(4):664-76. PubMed ID: 26500179
[TBL] [Abstract][Full Text] [Related]
26. Dialysis Therapy and Conservative Management of Advanced Chronic Kidney Disease in the Elderly: A Systematic Review.
Wongrakpanich S; Susantitaphong P; Isaranuwatchai S; Chenbhanich J; Eiam-Ong S; Jaber BL
Nephron; 2017; 137(3):178-189. PubMed ID: 28538218
[TBL] [Abstract][Full Text] [Related]
27. Experiences of US Nephrologists in the Delivery of Conservative Care to Patients With Advanced Kidney Disease: A National Qualitative Study.
Wong SPY; Boyapati S; Engelberg RA; Thorsteinsdottir B; Taylor JS; O'Hare AM
Am J Kidney Dis; 2020 Feb; 75(2):167-176. PubMed ID: 31570175
[TBL] [Abstract][Full Text] [Related]
28. Exploring the Evidence: Symptom Burden in Chronic Kidney Disease.
Clark-Cutaia MN; Rivera E; Iroegbu C; Arneson G; Deng R; Anastasi JK
Nephrol Nurs J; 2022; 49(3):227-255. PubMed ID: 35802361
[TBL] [Abstract][Full Text] [Related]
29. Supportive Care: Comprehensive Conservative Care in End-Stage Kidney Disease.
Murtagh FEM; Burns A; Moranne O; Morton RL; Naicker S
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1909-1914. PubMed ID: 27510453
[TBL] [Abstract][Full Text] [Related]
30. Patient-centred approaches for the management of unpleasant symptoms in kidney disease.
Kalantar-Zadeh K; Lockwood MB; Rhee CM; Tantisattamo E; Andreoli S; Balducci A; Laffin P; Harris T; Knight R; Kumaraswami L; Liakopoulos V; Lui SF; Kumar S; Ng M; Saadi G; Ulasi I; Tong A; Li PK
Nat Rev Nephrol; 2022 Mar; 18(3):185-198. PubMed ID: 34980890
[TBL] [Abstract][Full Text] [Related]
31. Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care.
Kurella Tamura M; O'Hare AM; Lin E; Holdsworth LM; Malcolm E; Moss AH
Am J Kidney Dis; 2018 Jun; 71(6):866-873. PubMed ID: 29510920
[TBL] [Abstract][Full Text] [Related]
32. The Prepare for Kidney Care Study: prepare for renal dialysis versus responsive management in advanced chronic kidney disease.
Murphy E; Burns A; Murtagh FEM; Rooshenas L; Caskey FJ
Nephrol Dial Transplant; 2021 May; 36(6):975-982. PubMed ID: 32940683
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Quality-of-Life Outcomes Following Invasive vs Conservative Treatment of Patients With Chronic Coronary Disease Across the Spectrum of Kidney Function.
Bangalore S; Hochman JS; Stevens SR; Jones PG; Spertus JA; O'Brien SM; Reynolds HR; Boden WE; Fleg JL; Williams DO; Stone GW; Sidhu MS; Mathew RO; Chertow GM; Maron DJ
JAMA Cardiol; 2022 Aug; 7(8):825-835. PubMed ID: 35767253
[TBL] [Abstract][Full Text] [Related]
34. Healthcare use, costs and quality of life in patients with end-stage kidney disease receiving conservative management: results from a multi-centre observational study (PACKS).
Phair G; Agus A; Normand C; Brazil K; Burns A; Roderick P; Maxwell AP; Thompson C; Yaqoob M; Noble H
Palliat Med; 2018 Sep; 32(8):1401-1409. PubMed ID: 29767579
[TBL] [Abstract][Full Text] [Related]
35. Conservative management of end-stage renal disease without dialysis: a systematic review.
O'Connor NR; Kumar P
J Palliat Med; 2012 Feb; 15(2):228-35. PubMed ID: 22313460
[TBL] [Abstract][Full Text] [Related]
36. Perspiration interventions for conservative management of kidney disease and uremia.
Keller RW; Kopple JD; Kalantar-Zadeh K
Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):57-63. PubMed ID: 31743242
[TBL] [Abstract][Full Text] [Related]
37. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
[TBL] [Abstract][Full Text] [Related]
38. Conservative management for patients with chronic kidney disease refusing dialysis.
Castro MCM
J Bras Nefrol; 2019; 41(1):95-102. PubMed ID: 30048562
[TBL] [Abstract][Full Text] [Related]
39. Keto-analogues and essential aminoacids and other supplements in the conservative management of chronic kidney disease.
Cupisti A; Bolasco P
Panminerva Med; 2017 Jun; 59(2):149-156. PubMed ID: 28001026
[TBL] [Abstract][Full Text] [Related]
40. Review of the efficacy of AST-120 (KREMEZIN
Asai M; Kumakura S; Kikuchi M
Ren Fail; 2019 Nov; 41(1):47-56. PubMed ID: 30732506
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
